Abstract
Innovation is essential for advancing and sustaining healthcare systems, particularly in hospitals. While innovation offers solutions to challenges such as chronic disease management, access to care, and patient safety, it also introduces significant ethical dilemmas for health leaders. This column explores the broad ethical issues associated with healthcare innovation, focusing on resource allocation, support for diverse healthcare professions, equitable access to care, and the emphasis on technology-based innovations. It highlights the complexities of funding innovation through government, private sector, universities, donors, and the unpaid work of healthcare providers. The column also addresses the disparities in innovation support across different professions and the potential for innovation to exacerbate healthcare inequities. Potential solutions are proposed, including the establishment of interdisciplinary councils, dedicated innovation funds, and public-private partnerships. By prioritizing ethical leadership and balanced innovation strategies, health leaders can ensure that advancements benefit all stakeholders, fostering a more equitable and sustainable healthcare system in Canada.
Introduction
Innovation is vital in the advancement and sustainability of our healthcare system, especially in hospitals. As the problems of chronic disease management, access to care, cost of care, patient safety, novel diseases, labour shortages, and public health emergencies have grown, science and human ingenuity have responded with innovative solutions. Unfortunately, innovation also has brought a host of ethical challenges for health leaders to navigate. This column discusses some of the broad ethical issues associated with healthcare innovation in general, specifically focusing on resource allocation, support for innovation, access to care, and the current focus on technology-based innovation. These issues, although often overlooked, are critical to ensuring that innovation benefits all constituents in the healthcare system. In addition, potential solutions to these challenges are explored with an emphasis on the role of ethical leadership in balancing innovation with other system goals.
Defining innovation
For the purposes of this column, innovation in healthcare is understood as the process of translating new ideas, methods, or technologies into tangible improvements in patient care, operational efficiency, and overall health system performance. Dan Breznitz, in his book “Innovation in Real Places, 1 ” makes a distinction between innovation and invention. Invention refers to the creation of new ideas or technologies, while innovation encompasses the practical application and widespread adoption of these inventions to achieve meaningful positive effects for patients and/or the health system.
Resource allocation: Who should pay for innovation?
Determining who should bear the costs of innovation is a complex and contentious issue. The primary sources of funding for hospital innovation include governments, the private sector, universities, donors, and the voluntary work of healthcare providers.
Government funding
In many countries, governments are the largest contributors to healthcare innovation. Public funding can ensure that the benefits of innovation are broadly accessible and not limited to those who can afford them. For example, Canada’s federal and provincial governments fund a wide range of healthcare innovation and research via organizations such as the Digital Technology Supercluster, the Strategic Innovation Fund, Ontario’s Health Innovation Program (HIP), Quebec’s Fonds de recherche du Québec – Santé (FRQS), and Alberta Innovates.
Challenges
While governments typically have significant financial resources at their disposal, they often are influenced heavily by the political agendas of the day, and funding priorities may shift with changes in leadership. The process of obtaining government funding can be slow and bureaucratic. For example, obtaining approval for a new medical device through government channels can take years, delaying its availability to patients. Government funding often comes with stringent regulations and requirements, limiting the flexibility of healthcare institutions to innovate. Hospitals may find it challenging to adapt to rapidly changing healthcare needs because of the rigid frameworks set by government funding bodies. Governments also may prioritize short-term cost savings over long-term investments in innovation. For example, during economic downturns, governments often cut funding for research and development projects in favour of immediate cost-saving measures, undermining future healthcare advancements.
Potential solutions
Dedicated innovation funds that are protected from budget cuts and political pressures would greatly facilitate ongoing innovation. These funds could be used to support high-impact projects and ensure a steady stream of resources for innovation. In addition, streamlining the approval process for innovative projects could reduce bureaucratic delays and allow for more agile responses to emerging healthcare needs. In those instances where public funds are used to support innovation, such funding also needs to be balanced carefully against risks of diverting scarce resources away from prevention, primary care, or providing essential services to marginalized populations.
Private sector funding
The private sector plays a leading role in funding healthcare innovation, particularly in the development of new technologies and pharmaceuticals. Companies such as Pfizer and Moderna were at the forefront of developing COVID-19 vaccines. These companies invested billions of dollars to bring these vaccines to market quickly, and they played a crucial role in controlling the pandemic. Health technology start-ups have pioneered many digital health solutions, such as virtual care platforms and chronic disease management tools. All of these innovations have been particularly valuable during the COVID-19 pandemic, enabling remote consultations and monitoring.
Challenges
Privately funded innovation is often driven by profit-driven priorities, rather than by patient need or public health priorities. Profit-driven innovation may focus on treatment and technology, over prevention and public health measures, or short-term return-on-investment rather than long-term societal benefit. Profit-driven innovation may also lead treatments and technologies that are either unaffordable to underserved populations, exacerbating healthcare inequities, or result in high-cost treatments that are adopted quickly into publicly funded care, again pulling resources away from prevention and public health measures. During the pandemic, we witnessed the high prices of mRNA vaccines in some countries raising ethical concerns about accessibility and equity. The pricing of new cancer treatments, which can run into hundreds of thousands of dollars per year, also illustrates this issue, as many patients struggle to afford these life-saving treatments.
Potential solutions
Public-Private Partnerships (PPPs) can be an effective way to balance the benefits of private investment with the need for equitable access. These partnerships involve agreements where private companies invest in innovation but agree to price caps or tiered pricing models that make treatments affordable for all patients. Governments can also offer tax incentives to companies that prioritize affordable pricing and equitable access. Advisory boards, composed of representatives from the public sector, private companies, healthcare providers, and patient advocacy groups, can guide the prioritization of innovation projects to ensure they meet public health needs while also being financially viable for private investors.
Universities
Academic institutions contribute significantly to healthcare innovation through research and development. Universities often partner with hospitals to test and implement new ideas.
Challenges
However, the commercialization of university research can raise ethical questions about intellectual property rights and the distribution of benefits. The case of the CRISPR-Cas9 gene-editing technology, which originated from university research, sparked debates about patent rights and accessibility of this revolutionary tool.
Potential solutions
Universities could adopt policies that prioritize public benefit over commercial interests when licensing technologies. This could include provisions that ensure affordable pricing and broad accessibility of innovations. Collaborative agreements between universities and hospitals should also emphasize shared goals of improving patient care and health outcomes.
Donors
Philanthropic contributions are another vital source of funding for hospital innovation. Donations can drive progress in specific areas of interest to donors.
Challenges
However, dependence on donors can create ethical dilemmas about prioritizing projects that align with donors’ preferences rather than the broader needs of the community.
Potential solutions
Hospitals can establish donor guidelines that align with their overall strategic goals and community needs. By clearly communicating these guidelines to donors, hospitals can ensure that philanthropic contributions support the most impactful and necessary projects. In addition, creating a diverse portfolio of funding sources can reduce dependence on any single donor and mitigate the risk of misaligned priorities.
Free work by providers
Healthcare providers often contribute to innovation through unpaid work, with research and innovation happening “off the clock.”
Challenges
While this can foster a culture of continuous improvement, it also raises ethical issues about the fair compensation and recognition of contributions. The burden of unpaid work can lead to burnout and reduced morale among healthcare providers, ultimately affecting patient care.
Potential solutions
Formal hospital innovation programs that provide dedicated time and resources for healthcare providers to pursue innovative projects can help ease the burden of uncompensated research and innovation. Such programs may include grants, sabbaticals, and recognition awards that acknowledge and reward the contributions of all healthcare professionals. Additionally, fostering a collaborative environment, where providers can share their ideas and work together on innovation projects, can help distribute the workload more equitably.
Inequitable support for professions involved in innovation
Innovation in hospitals benefits from the input of various healthcare professionals. However, there is a significant disparity in the support provided to different professions.
Challenges
Physicians, especially those in senior roles or working in hospitals with academic affiliations, typically are granted dedicated research time and resources to pursue innovative projects. In contrast, other healthcare professionals, such as nurses, allied health professionals, and administrative staff, often receive little or no financial support for innovation/research and far fewer opportunities to engage in innovation. In many hospitals, innovation portfolios are managed under the chief of staff, typically a physician. This structure inherently prioritizes projects led by doctors. For example, a hospital may fund a physician-led research project on a new surgical technique but neglect innovative nursing practices that could improve patient outcomes. Finally, the relentless pressure from governments to drive down the costs in hospitals leaves little time for healthcare leaders to think about innovation. This pressure can block leadership innovation by limiting the available resources and time needed for creative thinking and development. This broad disparity in how different professionals are engaged in innovation not only stifles valuable contributions from across the sector but also perpetuates a hierarchy that undervalues the role of non-physicians in healthcare innovation.
Potential solutions
Interdisciplinary innovation councils, including representatives from diverse healthcare professions and hospital departments, can help with a balanced approach to innovation support. Such councils can be responsible for identifying and prioritizing innovative projects, ensuring equitable access to innovation grants as well as leadership support for innovation. Hospitals also can establish dedicated innovation fellowships and research positions for nurses and allied health professionals. Providing protected time and resources for these professionals to pursue innovative projects can lead to more diverse innovations. Promoting interdisciplinary collaboration is essential for fostering a more inclusive approach to healthcare innovation. Hospitals that create innovation teams comprising diverse healthcare professionals, including nurses, allied health professions, and administrators, or otherwise promote innovation at the frontline, can leverage a broader range of insights and experiences. Finally, recognizing and celebrating the contributions of all healthcare workers through awards and public acknowledgments can help elevate their status within the healthcare innovation ecosystem.
Access to care
While new treatments and technologies can improve patient outcomes, they can also exacerbate existing disparities if not carefully managed. Often referenced in popular literature is the “digital divide,” caused by the rise of telemedicine, virtual care, and other digital health technologies. As digital tools and embedded artificial intelligence have become more common, they have exposed and exacerbated inequalities in access to technology and Internet connectivity among different populations.
Challenges
Some groups, particularly those who are economically disadvantaged, elderly, or living in rural areas, may be unable to benefit fully from these advancements in healthcare due to lack of access to the necessary technology, Internet, or digital literacy. Access to innovative treatments can also be geographically uneven. Rural hospitals and clinics often lack the resources and infrastructure to implement new technologies or treatments available in urban centres. Another significant concern is that resources allocated to innovation may divert funds from essential care delivery services. Hospitals operating on increasingly stretched budgets may face difficult decisions about whether to invest in innovative projects/technologies or maintain existing services, especially around treating underserved populations or maintaining programs without explicit funding. As discussed earlier, innovation also can result in new treatments that are prohibitively expensive, limiting access to those who can afford them.
Potential solutions
Hospitals can adopt a balanced funding approach that allocates resources to both innovation and essential care delivery. Establishing dedicated innovation funds, separate from the operating budget but with clear expectations, can ensure that innovation does not detract from core services. Involving the community in decision-making processes can help prioritize innovations that address the most pressing healthcare needs. Hospitals can also advocate for policies that promote the affordability and equitable distribution of innovative treatments. In addition, creating patient assistance programs can help bridge the gap for those who cannot afford high-cost treatments. Investments in digital infrastructure, such as expanding broadband access to rural and underserved areas, are essential for ensuring equitable access to digital health innovations. Providing digital literacy training for patients and healthcare providers also can help mitigate the digital divide. Hospitals should continue to partner with community organizations to offer training programs and support for patients who may struggle with digital technologies.
Innovation–not just new technology
Technological innovation and the rise of embedded artificial intelligence often overshadow other important areas of improvement in healthcare, such as quality, safety, and leadership. While technological advancements are crucial, they should not come at the expense of other forms of innovation that can improve both patient outcomes and healthcare efficiency.
Quality, safety, and people-centred care innovations
Innovations in these areas are essential for reducing medical errors, improving patient outcomes, and enhancing the overall healthcare experience. For example, the implementation of checklists in surgical procedures, a very low-tech solution, significantly reduced surgical complications and mortality rates. Hospitals need to continue to support quality, safety, and experience-focused innovation as part of overall innovation strategies, including supporting process improvement and best practices. Integrating quality, safety, and experience performance metrics into evaluation criteria for innovation funding and recognition can help maintain this focus.
Leadership innovations
Effective leadership is the foundation in a culture of innovation and for ensuring that hospitals can adapt to changing healthcare landscapes. Innovations in leadership practices, such as new models of governance, team-based approaches, and strategies for enhancing staff engagement, are essential for sustaining long-term improvements. Encouraging/resourcing leaders to pursue continuing education and training in these areas can enhance their ability to drive innovation—and promoting a leadership model that values collaboration, inclusivity, and continuous improvement can create a supportive environment for innovation.
Conclusion
Innovation in hospitals is necessary for advancing healthcare, but it also brings a many ethical challenges that health leaders must address. Ensuring equitable resource allocation, supporting all healthcare professions, maintaining access to care, and balancing technology with other forms of innovation are critical to fostering a fair and effective healthcare system. By addressing these ethical issues and implementing potential solutions, health leaders can ensure that innovation benefits all patients and contributes to a more just and sustainable healthcare future. The relentless pressure from governments to drive down costs adds to these challenges, but with strategic planning and a commitment to ethical principles, hospitals can navigate these complexities and continue to innovate to improve overall value for money in the healthcare system.
Footnotes
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
Ethical approval
Institutional review board approval was not required.